1-18 of 18
Milena Gilestro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial

Stefania Oliva, Elisa Genuardi, Maria Teresa Petrucci, Mattia D'Agostino, MD, Daniel Auclair, Antonio Spadano, Allison P. Jacob, Michele Cea, Luca De Rosa, Alessandro Gozzetti, Marina Ruggeri, Andrea Capra, Milena Gilestro, Norbert Pescosta, Angelo D. Palmas, Agostina Siniscalchi, Ilan R. Kirsch, Paolo Corradini, Pellegrino Musto, Mario Boccadoro, Elena Zamagni, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-137351
Published: 2020
Journal Articles

Characterization of B-Cell and Plasma Cell Compartment By Eight-Color Multiparameter Flow Cytometry in Patients with Waldenstrom Macroglobulinemia Prospectively Enrolled in the Fondazione Italiana Linfomi (FIL) BIO-WM Trial

Marzia Varettoni, Simone Ferrero, MD, Cristina Picone, Milena Gilestro, Noemí Puig, MD PhD, Luigi Marcheselli, Irene Dogliotti, MD, Angela Ferrari, Michele Merli, MD, Giulia Zamprogna, MD, Luca Laurenti, MD, Simona Tomassetti, MD, Emanuele Cencini, MD, Giacomo Loseto, MD, Dario Marino, MDPhD, Monia Marchetti, MD, Francesca Re, MD, Antonello Sica, MD, Jacopo Olivieri, Cristina Jiménez, PhD, Silvia Zibellini, PhD, Daniela Drandi, PhD, Chiara Candido, Martina Ferrante, PhD, Nicole Fabbri, Federica Cavallo, Luca Arcaini, Mario Boccadoro, Ramon Garcia-Sanz
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-137119
Published: 2020
Journal Articles

Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity

Luca Bertamini, MD, Mariella Grasso, Mattia D'Agostino, MD, Anna Pascarella, Patrizia Tosi, Federico Monaco, Francesco Pisani, Paola Bertazzoni, Milena Gilestro, Andrea Capra, Piero Galieni, Ombretta Annibali, Vincenzo Pavone, Stefano Molica, MD, Sonia Ronconi, Paola Tacchetti, Pellegrino Musto, Francesca Gay, MD, Mario Boccadoro, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-137075
Published: 2020
Journal Articles

Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients

Francesca Gay, MD, Gian Maria Zaccaria, Massimo Offidani, Federico Vozella, Paolo Becco, Angelo Belotti, Andrea Capra, Monica Galli, Fortunato Morabito, Luca Bertamini, Francesco Pisani, Piero Galieni, Rita Rizzi, Alessandro Gozzetti, Norbert Pescosta, Luca De Rosa, Franco Narni, Milena Gilestro, Salvatore Palmieri, Michele Cea, Patrizia Tosi, Nicola Giuliani, Pellegrino Musto, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2019) 134 (Supplement_1): 605.
https://doi.org/10.1182/blood-2019-125588
Published: 2019
Journal Articles

Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics

Vittorio Emanuele Muccio, Milena Gilestro, Elona Saraci, Andrea Capra, Alessandro Costa, Marina Ruggeri, Simona Caltagirone, Daniela Oddolo, Chiara Mussatto, Pellegrino Musto, Lucia Pantani, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Anna Maria Cafro, Claudia Cellini, Vanessa Innao, Eugenio Piro, Francesca Gay, MD, Mario Boccadoro, Paola Omedé
Journal: Blood
Blood (2019) 134 (Supplement_1): 4357.
https://doi.org/10.1182/blood-2019-122657
Published: 2019
Journal Articles

A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) Patients

Sara Bringhen, MD, Valeria Magarotto, MD, Anna Marina Liberati, MD, Angelo Belotti, MD, Alessandra Larocca, MD, Milena Gilestro, BSc, Francesca Bonello, MD, Gianluca Gaidano, MD PhD, Paola Bertazzoni, MD, Raffaella Stocchi, MD, Rossella Ribolla, MD, Chiara Di Sano, MD, Francesca Patriarca, Roberto Passera, PharmD, PhD, Lorenzo De Paoli, MD, Stefania Oliva, MD, Anna Maria Cafro, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2016) 128 (22): 1145.
https://doi.org/10.1182/blood.V128.22.1145.1145
Published: 2016
Journal Articles

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Davine Hofste op Bruinink, MD MSc, Stefania Oliva, MD, Lucie Rihova, PhD, Bronno van der Holt, PhD, Milena Gilestro, BSc, Jeroen G. te Marvelde, BSc, Pavla Vsianska, MSc, Alexander Schmitz, PhD, Helle Høholt, BSc, Hans Erik Johnsen, MDDMSc, Mario Boccadoro, MD, Roman Hajek, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, MD, Paola Omedè, PhD, Vincent H.J. van der Velden, PhD
Journal: Blood
Blood (2016) 128 (22): 2072.
https://doi.org/10.1182/blood.V128.22.2072.2072
Published: 2016
Journal Articles

Minimal Residual Disease Detection By Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: A Preliminary Analysis of the EMN02/HO95 MM Study

Stefania Oliva, Manuela Gambella, Milena Gilestro, Francesca Gay, Alessandra Larocca, Anna Marina Liberati, Francesca Bonello, Giulia Benevolo, Giovannino Ciccone, Tommaso Caravita, Vittorio Emanuele Muccio, Simona Caltagirone, Stefano Spada, Barbara Gamberi, Simone Ferrero, Marina Ruggeri, Giuseppe Rossi, Elona Saraci, Massimo Offidani, Maria Teresa Petrucci, Mario Boccadoro, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, Paola Omedè
Journal: Blood
Blood (2015) 126 (23): 1760.
https://doi.org/10.1182/blood.V126.23.1760.1760
Published: 2015
Journal Articles

In Multiple Myeloma, Minimal Residual Disease (MRD) Is an Early Predictor of Progression and Is Modulated By Maintenance Therapy with Lenalidomide

Manuela Gambella, Paola Omedè, Stefania Oliva, MD, Milena Gilestro, Vittorio Emanuele Muccio, Daniela Drandi, Simone Ferrero, MD, Francesca Gay, MD, Francesca Patriarca, MD, Carmela Palladino, MD, Maria Teresa Petrucci, MD, Norbert Pescosta, MD, Anna Marina Liberati, MD, Tommaso Caravita, MD, Francesco Di Raimondo, MD, Alberto Rocci, MD, Pellegrino Musto, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 3394.
https://doi.org/10.1182/blood.V124.21.3394.3394
Published: 2014
Journal Articles

Immunophenotypic Response After Allografting In Multiple Myeloma

Luisa Giaccone, MD, Lucia Brunello, Roberto Passera, Moreno Festuccia, MD, Milena Gilestro, Enrico Maffini, Federica Ferrando, Mario Boccadoro, MD, Paola Omedè, MD, Benedetto Bruno
Journal: Blood
Blood (2013) 122 (21): 3371.
https://doi.org/10.1182/blood.V122.21.3371.3371
Published: 2013
Journal Articles

A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Valeria Magarotto, Sara Bringhen, MD, Massimo Offidani, MD, Giuseppe Pietrantuono, MD, Anna Marina Liberati, MD, Giulia Benevolo, MD, Antonio Ledda, MD, Milena Gilestro, Monica Galli, MD, Francesca Patriarca, MD, Mariella Genuardi, MD, Nicola Giuliani, MD, Renato Zambello, MD, Adam Zdenek, Alessia La Fauci, MD, Paolo Corradini, Antonietta Pia Falcone, MD, Caterina Musolino, MD, Davide Rossi, MD, Ph.D., Patrizia Caraffa, MD, Pellegrino Musto, MD, Federica Cavallo, MD, Roman Hajek, MD, PhD, Mario Boccadoro, MD
Journal: Blood
Blood (2013) 122 (21): 536.
https://doi.org/10.1182/blood.V122.21.536.536
Published: 2013
Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients

Antonio Palumbo, MD, Sara Bringhen, Oreste Villani, Agostina Siniscalchi, MD, Eleonora Russo, MD, PhD, Giuseppina Uccello, MD, Chiara Cerrato, MD, Milena Gilestro, Davide Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 730.
https://doi.org/10.1182/blood.V120.21.730.730
Published: 2012
Journal Articles

Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors

Antonio Palumbo, Sara Bringhen, Maide Cavalli, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Renato Zambello, Giuseppe Pietrantuono, Luca De Rosa, Anna Marina Liberati, Claudia Crippa, Giulia Perrone, Fabrizio Ciambelli, Angelo Michele Carella, Salvatore Palmieri, Milena Gilestro, Valeria Magarotto, Maria Teresa Petrucci, Pellegrino Musto, Gianluca Gaidano, Mario Boccadoro
Journal: Blood
Blood (2010) 116 (21): 620.
https://doi.org/10.1182/blood.V116.21.620.620
Published: 2010
Journal Articles

Immune Reconstitution and Thymic Function After Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Benedetto Bruno, Paola Omedè, Silvia Cena, Maddalena Noviello, Milena Gilestro, Laura Cimolin, Silvia Mattia, Cristian Sfiligoi, Elisa Galletto, Luciana Veneziano, Luisa Giaccone, Roberto Sorasio, MD, Moreno Festuccia, Federica Ferrando, Lucia Brunello, Massimo Massaia, MD, Alessandro Aiuti, Chiara Bonini, Roberto Passera, PhD, Franca Fagioli, Mario Boccadoro
Journal: Blood
Blood (2010) 116 (21): 1254.
https://doi.org/10.1182/blood.V116.21.1254.1254
Published: 2010
Journal Articles

Met Over-Expression Is a Prognostic Factor for Myeloma Patients Treated with Novel Agents.

Albero Rocci, MD, Francesca Gay, MD, Livio Trusolino, MD, Paola Omedè, PhD, Andrea Bertotti, MD, Vittorio Montefusco, MD, Claudia Crippa, MD, Francesca Patriarca, MD, Milena Gilestro, PhD, Anna M. Liberati, MD, Fausto Rossini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Giuseppe Rossi, MD, Daniela Drandi, PhD, Paolo Corradini, MD, Marco Ladetto, MD, Paolo M. Comoglio, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2009) 114 (22): 1821.
https://doi.org/10.1182/blood.V114.22.1821.1821
Published: 2009
Journal Articles

Thymic Function Following Nonmyeloablative Allografting for the Treatment of Hematological Malignancies

Benedetto Bruno, Roberto Sorasio, Silvia Cena, Christian Sfiligoi, Luisa Giaccone, Marcella Spagnolo, Milena Gilestro, Fulvia Giaretta, Rainer F. Storb, Paola Omedè, Mario Boccadoro
Journal: Blood
Blood (2008) 112 (11): 4344.
https://doi.org/10.1182/blood.V112.11.4344.4344
Published: 2008
Journal Articles

Bortezomib-Doxorubicin-Dexamethasone as Induction Prior to Reduced Intensity Autologous Transplantation Followed by Lenalidomide as Consolidation/Maintenance in Elderly Untreated Myeloma Patients

Antonio Palumbo, MD, Patrizia Falco, MD, Francesca Gay, MD, Vittorio Montefusco, MD, Claudia Crippa, MD, Francesca Patriarca, MD, Milena Gilestro, PhD, Anna M. Liberati, MD, Fausto Rossini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Federica Cavallo, MD, Paolo Corradini, MD, Giuseppe Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2008) 112 (11): 159.
https://doi.org/10.1182/blood.V112.11.159.159
Published: 2008
Journal Articles

A New Acute Monoblastic Leukemia Cell Line Expressing Vascular Endotelial Growth Factor (VEGF) -A and -D and VEGF Receptor-3 (Flt-4).

Dario Ferrero, MD, Graziella Bellone, Ph D, Valentina Giai, M D, Anna Carbone, Ph D, Patrizia Scaravaglio, Ph D, Chiara Dellacasa, M D, Milena Gilestro, Ph D, Mario Boccadoro, MD
Journal: Blood
Blood (2006) 108 (11): 4496.
https://doi.org/10.1182/blood.V108.11.4496.4496
Published: 2006